Cargando…
Renal-Protective Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone in ob/ob Mice
BACKGROUND: This study investigated the therapeutic effects of the peroxisome proliferator-activated receptor-γ (PPARγ) agonist pioglitazone in ob/ob mice with obesity-related glomerulopathy (ORG). MATERIAL/METHODS: A total of 24 mice were divided into 3 groups: wild-type C57BL/6 mice (n=8), ob/ob m...
Autores principales: | Li, Ying, Xia, Tian, Li, Rong, Tse, Gary, Liu, Tong, Li, Guangping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407328/ https://www.ncbi.nlm.nih.gov/pubmed/30820023 http://dx.doi.org/10.12659/MSM.913461 |
Ejemplares similares
-
Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor δ from Peroxisome proliferator-activated receptor γ in the ob/ob mouse
por: Roberts, Lee D, et al.
Publicado: (2009) -
Effects of CP-900691, A Novel Peroxisome Proliferator-Activated Receptor α Agonist on Diabetic Nephropathy in the BTBR ob/ob mouse
por: Askari, Bardia, et al.
Publicado: (2014) -
Abdominal Irradiation Ameliorates Obesity in ob/ob Mice
por: Okada, Sumiyo, et al.
Publicado: (2007) -
The Physiology of Obese-Hyperglycemic Mice [ob/ob Mice]
por: Lindström, Per
Publicado: (2007) -
The Amelioration of Hepatic Steatosis by Thyroid Hormone Receptor Agonists Is Insufficient to Restore Insulin Sensitivity in Ob/Ob Mice
por: Martagón, Alexandro J., et al.
Publicado: (2015)